| Patent | Date |
|---|
Method of treating idiopathic pulmonary fibrosis and kidney fibrosis
Grant 11,345,748 - Hotamisligil , et al. May 31, 2 | 2022-05-31 |
Anti-ap2 Antibodies And Antigen Binding Agents To Treat Metabolic Disorders
App 20220089705 - Hotamisligil; Gokhan S. ; et al. | 2022-03-24 |
Compounds Useful To Treat Metabolic Disorders
App 20210171599 - Hotamisligil; Gokhan S. ; et al. | 2021-06-10 |
Anti-AP2 antibodies and antigen binding agents to treat metabolic disorders
Grant 11,014,979 - Hotamisligil , et al. May 25, 2 | 2021-05-25 |
SECRETED aP2 AND METHODS OF INHIBITING SAME
App 20210147527 - Hotamisligil; Gokhan S. ; et al. | 2021-05-20 |
Methods of treating diabetes by an adipocyte protein 2 specific antibody
Grant 10,882,901 - Hotamisligil , et al. January 5, 2 | 2021-01-05 |
Method To Identify Compounds Useful To Treat Dysregulated Lipogenesis, Diabetes, And Related Disorders
App 20200102380 - Hotamisligil; Gokhan S. ; et al. | 2020-04-02 |
Anti-ap2 Antibodies And Antigen Binding Agents To Treat Metabolic Disorders
App 20190161536 - Hotamisligil; Gokhan S. ; et al. | 2019-05-30 |
Compounds Useful To Treat Metabolic Disorders
App 20190135888 - Hotamisligil; Gokhan S. ; et al. | 2019-05-09 |
Anti-aP2 antibodies and antigen binding agents to treat metabolic disorders
Grant 10,160,798 - Hotamisligil , et al. Dec | 2018-12-25 |
Use of trans-palmitoleate in identifying and treating metabolic disease
Grant 9,987,243 - Mozaffarian , et al. June 5, 2 | 2018-06-05 |
SECRETED aP2 AND METHODS OF INHIBITING SAME
App 20180105586 - Hotamisligil; Gokhan S. ; et al. | 2018-04-19 |
Method of treating lipodystrophy in HIV-infected humans
Grant 9,879,078 - Hotamisligil , et al. January 30, 2 | 2018-01-30 |
Use Of Trans-palmitoleate In Identifying And Treating Metabolic Disease
App 20160361284 - Mozaffarian; Dariush ; et al. | 2016-12-15 |
Anti-aP2 Antibodies and Antigen Binding Agents to Treat Metabolic Disorders
App 20160319003 - Hotamisligil; Gokhan S. ; et al. | 2016-11-03 |
Secreted aP2 and Methods of Inhibiting Same
App 20160297874 - Hotamisligil; Gokhan S. ; et al. | 2016-10-13 |
Fatty acid C16: 1N7-palmitoleate a lipokine and biomarker for metabolic status
Grant 9,239,334 - Cao , et al. January 19, 2 | 2016-01-19 |
Use Of Trans-palmitoleate In Identifying And Treating Metabolic Disease
App 20160008309 - Mozaffarian; Dariush ; et al. | 2016-01-14 |
Use of trans-palmitoleate in identifying and treating metabolic disease
Grant 8,889,739 - Mozaffarian , et al. November 18, 2 | 2014-11-18 |
Targets For Treatment Of Er Stress
App 20140228422 - Hotamisligil; Gokhan S. ; et al. | 2014-08-14 |
Modulating Endoplasmic Reticulum Stress in the Treatment of Tuberous Sclerosis
App 20140011761 - Hotamisligil; Gokhan S. ; et al. | 2014-01-09 |
Use Of Trans-palmitoleate In Identifying And Treating Metabolic Disease
App 20130267599 - Mozaffarian; Dariush ; et al. | 2013-10-10 |
Secreted Ap2 And Methods Of Inhibiting Same
App 20120134998 - Hotamisligil; Gokhan S. ; et al. | 2012-05-31 |
Fatty Acid C16: 1n7-palmitoleate A Lipokine And Biomarker For Metabolic Status
App 20110213032 - Cao; Haiming ; et al. | 2011-09-01 |
Reducing Er Stress In The Treatment Of Obesity And Diabetes
App 20100075894 - Hotamisligil; Gokhan S. ; et al. | 2010-03-25 |
Modulating Endoplasmic Reticulum Stress In The Treatment Of Tuberous Sclerosis
App 20100022495 - Hotamisligil; Gokhan S. ; et al. | 2010-01-28 |
Methods For Treating Hypercholesterolemia And Atherosclerosis
App 20090312297 - Hotamisligil; Gokhan S. ; et al. | 2009-12-17 |
Inhibiting formation of atherosclerotic lesions
App 20090012020 - Lee; Mu-En ; et al. | 2009-01-08 |
Inhibition of Jun Kinase
App 20070207137 - Hotamisligil; Gokhan S. ; et al. | 2007-09-06 |
Compositions and methods for modulating NH2-terminal Jun Kinase activity
Grant 7,232,897 - Hotamisligil , et al. June 19, 2 | 2007-06-19 |
Method of diagnosing a risk of developing insulin resistance
Grant 7,056,662 - Hotamisligil June 6, 2 | 2006-06-06 |
Reducing ER stress in the treatment of obesity and diabetes
App 20060073213 - Hotamisligil; Gokhan S. ; et al. | 2006-04-06 |
Modulation of XBP-1 activity for treatment of metabolic disorders
App 20060063187 - Hotamisligil; Gokhan S. ; et al. | 2006-03-23 |
Inhibition of jun kinase
App 20050261247 - Hotamisligil, Gokhan S. ; et al. | 2005-11-24 |
Inhibition of adipogenesis
App 20010046966 - Hotamisligil, Gokhan S. ; et al. | 2001-11-29 |
Inhibition of mal1
App 20010044110 - Hotamisligil, Gokhan S. | 2001-11-22 |
Treatment of insulin resistance in obesity linked type II diabetes using antagonists to TNF-.alpha. function
Grant 6,015,558 - Hotamisligil , et al. January 18, 2 | 2000-01-18 |
Treatment of insulin resistance in obesity linked type II diabetes using antagonist to TNF-alpha function
Grant 5,730,975 - Hotamisligil , et al. March 24, 1 | 1998-03-24 |
| 